RecruitingNCT05587439

Investigating Hereditary Risk In Thoracic Cancers (INHERIT)


Sponsor

Dana-Farber Cancer Institute

Enrollment

500 participants

Start Date

Jan 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this research study is to learn more about the inherited risk for developing lung cancer.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is researching whether lung cancer can run in families due to inherited gene changes. Researchers want to understand who carries these genetic variants and what their health outcomes look like over time. **You may be eligible if...** - You have a known or suspected inherited gene change (such as EGFR) that may be linked to lung cancer risk - You have lung cancer and a close family member who also had lung cancer - You have a family history of lung cancer across multiple generations - You have had more than one primary lung cancer or cancer in multiple spots in the lung - You are a blood relative of someone who fits any of the above descriptions **You may NOT be eligible if...** - You are not willing or able to give consent, and do not have a healthcare proxy to do so on your behalf Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICData and Specimen Collection

* Provide blood and/or saliva sample * Answer short questionnaires * Consider consenting to other optional parts of the research such as: * use stored tissue samples related to prior cancer treatment * Allow access to deceased relatives' medical records and stored specimens * Provide blood 1x per year for up to 5 years * Provide contact information of family members


Locations(2)

Brigham and Women's Hospital

Boston, Massachusetts, United States

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05587439


Related Trials